Retour
Fourchette du Jour
8,03 €
8,36 €
Fourchette 52 Semaines
5,80 €
16,44 €
Volume
3 745 404
Moyenne 50J / 200J
9,58 €
/
11,13 €
Clôture Précédente
8,18 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,6 | 0,4 |
| P/B | 2,7 | 2,9 |
| ROE % | -54,9 | 3,7 |
| Net Margin % | -513,2 | 3,8 |
| Rev Growth 5Y % | 4,5 | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
Revenue grew 4,46% annually over 5 years — modest growth
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -216,89M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23,13%
Croissance
Revenue Growth (5Y)
4,46%
Revenue (1Y)-18,67%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-54,85%
ROIC-27,59%
Net Margin-513,17%
Op. Margin-521,04%
Sécurité
Debt / Equity
0,12
Current Ratio15,39
Interest Coverage-22,82
Valorisation
P/E Ratio
-6,63
P/B Ratio2,69
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -18,67% | Revenue Growth (3Y) | -5,83% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4,46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 51,82M | Net Income (TTM) | -265,94M |
| ROE | -54,85% | ROA | -32,91% |
| Gross Margin | 87,31% | Operating Margin | -521,04% |
| Net Margin | -513,17% | Free Cash Flow (TTM) | -216,89M |
| ROIC | -27,59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 15,39 |
| Interest Coverage | -22,82 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,63 | P/B Ratio | 2,69 |
| P/S Ratio | 34,03 | PEG Ratio | -0,52 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,76B | Enterprise Value | 1,11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 51,82M | 63,72M | 58,44M | 51,49M | 43,52M |
| Net Income | -265,94M | -193,51M | -80,74M | -71,04M | -6,55M |
| EPS (Diluted) | -1,42 | -1,22 | -1,02 | -0,97 | -0,98 |
| Gross Profit | 45,25M | 58,10M | 53,16M | 46,95M | 39,12M |
| Operating Income | -270,02M | -171,78M | -82,38M | -78,65M | -78,04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 808,06M | 457,94M | 252,06M | 149,29M | 204,89M |
| Total Liabilities | 153,75M | 142,59M | 160,93M | 113,91M | 116,89M |
| Shareholders' Equity | 654,31M | 315,34M | 91,13M | 35,38M | 88,00M |
| Total Debt | 79,78M | 75,78M | 83,39M | 64,28M | 58,98M |
| Cash & Equivalents | 737,06M | 392,10M | 195,81M | 102,30M | 164,16M |
| Current Assets | 782,13M | 440,99M | 232,24M | 129,63M | 191,30M |
| Current Liabilities | 50,81M | 41,35M | 34,90M | 31,40M | 26,34M |